| MYC in oncogenesis and as a target for cancer therapies A Albihn, JI Johnsen, MA Henriksson Advances in cancer research 107, 163-224, 2010 | 323 | 2010 |
| Neuroblastoma—a neural crest derived embryonal malignancy JI Johnsen, C Dyberg, M Wickström Frontiers in molecular neuroscience 12, 9, 2019 | 267 | 2019 |
| Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance M Wickström, C Dyberg, J Milosevic, C Einvik, R Calero, ... Nature communications 6 (1), 8904, 2015 | 240 | 2015 |
| Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target N Baryawno, A Rahbar, N Wolmer-Solberg, C Taher, J Odeberg, A Darabi, ... The Journal of clinical investigation 121 (10), 4043-4055, 2011 | 237 | 2011 |
| The antimicrobial peptide, lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivo LT Eliassen, G Berge, A Leknessund, M Wikman, I Lindin, C Løkke, ... International Journal of Cancer 119 (3), 493-500, 2006 | 230 | 2006 |
| Inhibitors of mammalian target of rapamycin downregulate MYCN protein expression and inhibit neuroblastoma growth in vitro and in vivo JI Johnsen, L Segerström, A Orrego, L Elfman, M Henriksson, B Kågedal, ... Oncogene 27 (20), 2910-2922, 2008 | 213 | 2008 |
| Small-molecule inhibitors of phosphatidylinositol 3-kinase/Akt signaling inhibit Wnt/β-catenin pathway cross-talk and suppress medulloblastoma growth N Baryawno, B Sveinbjörnsson, S Eksborg, CS Chen, P Kogner, ... Cancer research 70 (1), 266-276, 2010 | 178 | 2010 |
| Omega-3 fatty acids in cancer, the protectors of good and the killers of evil? H Gleissman, JI Johnsen, P Kogner Experimental cell research 316 (8), 1365-1373, 2010 | 168 | 2010 |
| Cyclooxygenase-2 Is Expressed in Neuroblastoma, and Nonsteroidal Anti-Inflammatory Drugs Induce Apoptosis and Inhibit Tumor Growth In vivo JI Johnsen, M Lindskog, F Ponthan, I Pettersen, L Elfman, A Orrego, ... Cancer research 64 (20), 7210-7215, 2004 | 164 | 2004 |
| MYCN function in neuroblastoma development J Otte, C Dyberg, A Pepich, JI Johnsen Frontiers in oncology 10, 624079, 2021 | 161 | 2021 |
| Targeting suppressive myeloid cells potentiates checkpoint inhibitors to control spontaneous neuroblastoma Y Mao, N Eissler, KL Blanc, JI Johnsen, P Kogner, R Kiessling Clinical Cancer Research 22 (15), 3849-3859, 2016 | 148 | 2016 |
| Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo M Wickström, C Dyberg, T Shimokawa, J Milosevic, N Baryawno, ... International journal of cancer 132 (7), 1516-1524, 2013 | 146 | 2013 |
| Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cells H Hanaka, SC Pawelzik, JI Johnsen, M Rakonjac, K Terawaki, ... Proceedings of the National Academy of Sciences 106 (44), 18757-18762, 2009 | 139 | 2009 |
| p53‐mediated negative regulation of stathmin/Op18 expression is associated with G2/M cell‐cycle arrest JI Johnsen, ON Aurelio, Z Kwaja, GE Jörgensen, NS Pellegata, R Plattner, ... International journal of cancer 88 (5), 685-691, 2000 | 123 | 2000 |
| Pharmacologic activation of p53 triggers viral mimicry response thereby abolishing tumor immune evasion and promoting antitumor immunity X Zhou, M Singh, G Sanz Santos, V Guerlavais, LA Carvajal, M Aivado, ... Cancer discovery 11 (12), 3090-3105, 2021 | 117 | 2021 |
| A possible contributory role of BK virus infection in neuroblastoma development T Flægstad, PA Andresen, JI Johnsen, SK Asomani, GE Jørgensen, ... Cancer Research 59 (5), 1160-1163, 1999 | 115 | 1999 |
| Noncoding control region of naturally occurring BK virus variants: sequence comparison and functional analysis U Moens, T Johansen, JI Johnsen, OM Seternes, T Traavik Virus Genes 10, 261-275, 1995 | 115 | 1995 |
| COX/mPGES-1/PGE2 pathway depicts an inflammatory-dependent high-risk neuroblastoma subset K Larsson, A Kock, H Idborg, M Arsenian Henriksson, T Martinsson, ... Proceedings of the National Academy of Sciences 112 (26), 8070-8075, 2015 | 113 | 2015 |
| Docosahexaenoic acid metabolome in neural tumors: identification of cytotoxic intermediates H Gleissman, R Yang, K Martinod, M Lindskog, CN Serhan, JI Johnsen, ... The FASEB Journal 24 (3), 906, 2010 | 111 | 2010 |
| Tumor-growth–promoting cyclooxygenase-2 prostaglandin E2 pathway provides medulloblastoma therapeutic targets N Baryawno, B Sveinbjornsson, S Eksborg, A Orrego, L Segerstrom, ... Neuro-oncology 10 (5), 661-674, 2008 | 101 | 2008 |